The FinHealth 2017 Follow-up Study

The survey data collection has ended. We want to thank everyone who participated! There are more than 5,300 participants.

The survey was carried out 29th October 2020 to 21st January 2021. 

The research results will be published in Finnish on the web page Seurantatutkimuksen tuloksia.

What is the FinHealth 2017 follow-up Study?    

The same persons were invited in the follow-up study as in the FinHealth 2017 Study. The invited persons have been drawn by random sampling from the data of the Population Information System. Nearly, 10, 000 persons were invited to participate in the study.

The FinHealth 2017 Follow-up Study is implemented by the Finnish Institute for Health and Welfare (THL). This survey has been accepted by the Ethics Committee of the Hospital District of Helsinki and Uusimaa as being part of the FinHealth 2017 Study.

The aims of the follow-up study

The purpose of the FinHealth 2017 Study is to collect up-to-date information on the health and well-being, functional capacity as well as needs and use of health services among adult residents in Finland, and on the factors influencing their health and well-being. Through the follow-up study we aim to find out how these factors have been affected by the coronavirus epidemic. The information provided by the survey will be used to investigate measures needed for the prevention, management and treatment of epidemics such as the corona virus (COVID-19) epidemic. The survey results will be applied to develop actions and recommendations to reduce the burden caused by the epidemic.

The Finnish Institute for Health and Welfare is a public authority that stores and processes data in keeping with its secrecy obligation and in compliance with the data protection regulations. All persons involved in processing your data have a duty of non-disclosure. Individual respondents cannot be identified in the findings.

More information on the study

by e-mail at: [email protected]
 
Research Manager
Päivikki Koponen
[email protected]

Research Co-ordinator
Noora Ristiluoma 
[email protected]